Flow Cytometric Analysis of Peripheral Blood Neutrophil Myeloperoxidase Expression and Myelodysplastic Syndromes

CompletedOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

February 22, 2018

Primary Completion Date

September 6, 2018

Study Completion Date

September 6, 2018

Conditions
Myelodysplastic SyndromesChronic Myelomonocytic Leukemia
Interventions
DIAGNOSTIC_TEST

Flow cytometry analysis of neutrophil myeloperoxidase expression

"Flow cytometry analysis of neutrophil myeloperoxidase expression in peripheral blood samples will be performed within 24 h of MDS diagnostic evaluation and blinded to the reference standard. Peripheral blood samples will be collected in 5 ml (EDTA) anticoagulant plastic tubes and processed within 24 h maximum of collection. The samples will be stored at 4°C overnight.~Blood samples containing at least 105 neutrophils will be incubated with a panel of antibodies conjugated to fluorochromes, according to the manufacturers' recommendations.~At least 10,000 cell events will be acquired on a 3-laser, 8-color flow cytometer and analyzed using Becton Dickinson (BD) Fluorescence-activated cell sorting (FACS) Diva Software version 6. Each marker will be expressed as median, geometric and arithmetic mean, regular and robust coefficient of variation."

Trial Locations (2)

38043

Centre Hospitalier Universitaire Grenoble Alpes, Grenoble

63003

Centre Hospitalier Universitaire Estaing, Clermont-Ferrand

All Listed Sponsors
lead

University Hospital, Grenoble

OTHER

NCT03363399 - Flow Cytometric Analysis of Peripheral Blood Neutrophil Myeloperoxidase Expression and Myelodysplastic Syndromes | Biotech Hunter | Biotech Hunter